Radioimmunoassay technique is basically used to measure the concentration of specific antigens by using specific antibodies. This technique is mainly used for research purposes rather than for diagnostics purposes. The global radioimmunoassay (RIA) market constituted 2.3% share of the global immunoassay market.
Radioimmunoassay has applications in the field of clinical diagnostics, and is used in hospitals, contract research organizations (CRO), laboratories, pharmaceutical companies, and others. It is used for the early detection and diagnosis of cancer; recognition of endocrine logical disorders; and various other applications. Pharmaceuticals companies use the RIA techniques for drug testing. Radioimmunoassay also has it application in the research purpose, and contributed a share of 65.9% to the overall radioimmunoassay market in 2014.
Complete research of 75 market data tables & 68 figures spread through 113 pages and in-depth TOC on "Radioimmunoassay Market" at http://www.reportsnreports.com/reports/430222-radioimmunoassay-market-by-type-reagents-kits-analyzers-end-user-hospital-pharmaceutical-industry-academics-clinical-diagnostic-labs-application-research-clinical-diagnostics-and-geography-global-forecast-to-2020.html .
The global radioimmunoassay market is expected to reach $428.4 million by 2020, at a CAGR of 3.5% during the forecast period from 2015 to 2020. The growing aging population and rise in the usage of radioimmunoassay technique in Oncology are the major factors influencing this market.
There are various application areas for RIA in research and diagnostics, which are infectious disease testing, endocrine testing, allergy testing, oncology testing, toxicology testing, and autoimmune disease testing. Out of all the application segments, oncology testing is the largest application segment, and is expected to hold the largest market share in the near future. The major reason behind these is the growth in the oncology market due to various factors, such as the increasing incidence rate of cancer, growth in aging population, urbanization with heavy pollution, and others.
Click here for more discount on this research http://www.reportsnreports.com/contacts/discount.aspx?name=430222 .
The global radioimmunoassay market report studies the major regions, namely, North America, Europe, Asia, and the Rest of the World (RoW). The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis.
Some of the companies profiled in this report are DIAsource Immuno Assays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany),among others.
Single user license, a sample copy of “Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020” research report can be requested at http://www.reportsnreports.com/contacts/requestsample.aspx?name=430222 .
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013